Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Okumura

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
Current Eye Research|December 8, 2019
Regeneration of the Corneal EndotheliumNaoki Okumura, Noriko Koizumi
Cornea|September 5, 2014
Cell-based approach for treatment of corneal endothelial dysfunctionNaoki Okumura, Shigeru Kinoshita, Noriko Koizumi
Japanese Journal of Ophthalmology|August 18, 2025
Clinical characteristics and risk factors for corneal guttae in Japanese cataract patientsMasayo Niwa, Kengo Yoshii, Naoki Okumura
The Open Ophthalmology Journal|August 21, 2018
Perspective of Future Potent Therapies for Fuchs Endothelial Corneal DystrophyNaoki Okumura, Ryousuke Hayashi, Noriko Koizumi
Experimental Eye Research|November 10, 2011
Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal modelsNoriko Koizumi, Naoki Okumura, Shigeru Kinoshita
Current Pharmaceutical Design|December 6, 2016
The Role of Rho Kinase Inhibitors in Corneal Endothelial DysfunctionNaoki Okumura, Shigeru Kinoshita, Noriko Koizumi
Journal of Ophthalmology|July 29, 2017
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial DiseasesNaoki Okumura, Shigeru Kinoshita, Noriko Koizumi
Nagoya Journal of Medical Science|April 10, 2019
＜Editors' Choice＞ Pulmonary Hypertension: Diagnosis, Management, and TreatmentTakahisa Kondo, Naoki Okumura, Shiro Adachi, et al.
Investigative Ophthalmology & Visual Science|August 22, 2018
Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Corneal Endothelial Cell ProliferationMakiko Nakahara, Naoki Okumura, Shinichiro Nakano, et al.
Cornea|October 8, 2014
New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye dropsNoriko Koizumi, Naoki Okumura, Morio Ueno, et al.
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Current Eye Research|December 8, 2019
Regeneration of the Corneal EndotheliumNaoki Okumura, Noriko Koizumi
Cornea|September 5, 2014
Cell-based approach for treatment of corneal endothelial dysfunctionNaoki Okumura, Shigeru Kinoshita, Noriko Koizumi
Japanese Journal of Ophthalmology|August 18, 2025
Clinical characteristics and risk factors for corneal guttae in Japanese cataract patientsMasayo Niwa, Kengo Yoshii, Naoki Okumura
The Open Ophthalmology Journal|August 21, 2018
Perspective of Future Potent Therapies for Fuchs Endothelial Corneal DystrophyNaoki Okumura, Ryousuke Hayashi, Noriko Koizumi
Experimental Eye Research|November 10, 2011
Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal modelsNoriko Koizumi, Naoki Okumura, Shigeru Kinoshita
Current Pharmaceutical Design|December 6, 2016
The Role of Rho Kinase Inhibitors in Corneal Endothelial DysfunctionNaoki Okumura, Shigeru Kinoshita, Noriko Koizumi
Journal of Ophthalmology|July 29, 2017
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial DiseasesNaoki Okumura, Shigeru Kinoshita, Noriko Koizumi
Nagoya Journal of Medical Science|April 10, 2019
＜Editors' Choice＞ Pulmonary Hypertension: Diagnosis, Management, and TreatmentTakahisa Kondo, Naoki Okumura, Shiro Adachi, et al.
Investigative Ophthalmology & Visual Science|August 22, 2018
Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Corneal Endothelial Cell ProliferationMakiko Nakahara, Naoki Okumura, Shinichiro Nakano, et al.
Cornea|October 8, 2014
New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye dropsNoriko Koizumi, Naoki Okumura, Morio Ueno, et al.
Pageof 24